IVD Market Competitive Research And Precise Outlook 2023 To 2030

1
Contrive Datum InsightsGlobal Research And
Consulting
A complete solution to explore all the potential
aspect to drive the growth of the business
industries.
IVD Market
2
About Us
Contrive Datum Insights (CDI) is a market
intelligence company providing global business
information reports and services. Our exclusive
blend of quantitative forecasting and trends
analysis provides forward-looking insight for
thousands of decision makers. CDIs experienced
team of Analysts, Researchers, and Consultants
uses proprietary data sources and various tools
and techniques to gather, and analyse
information. Our business offerings represent the
latest and the most reliable information
indispensable for businesses to sustain a
competitive edge. Each CDI syndicated research
report covers a different sector such as
chemicals, materials, metals mining,
pharmaceuticals, energy, automotive, food and
beverages, semiconductors, med-devices, consumer
goods and information technology. These reports
provide in-depth analysis and deep segmentation
to possible micro levels. With wider scope and
stratified research methodology, our syndicated
reports strive to serve the overall research
requirement of clients.
3
Services O?ered

• Market Intelligence Market Opportunity
  Assessment
• Market Size Segmentation
• Market Entry Strategy
• Competitor Benchmarking
• Pricing Intelligence
• Customer Intelligence
• Sourcing Intelligence
• New-Generation Products Technologies
• Distribution Sales Channel Assessment

4
Clientele
Some of the global leading clients that we have
served
5
Clientele
Some of the global leading clients that we have
served
6
Market Overview
This expansion is a direct result of the
epidemic-driven uptick in demand for IVDs. Growth
in the market is anticipated to be driven by the
introduction of automated IVD systems into
hospitals and laboratories, which will allow for
quick, precise, and error-free diagnosis. Market
expansion is also being driven by the
proliferation of new in vitro diagnostic (IVD)
products from key manufacturers. Molecular
diagnostics used in IVD products allow for
reliable and precise diagnosis.A highly sensitive
molecular test was created in May 2021 at the
University of California, Berkeley. This
examination utilizes chip technology that can
identify influenza A and SARS-CoV-2 antigens.
Research is continuing on the feasibility of
adapting this assay for use at the Point-of-Care
(POC). The industry's dynamics have changed as
more companies prioritize ground-floor testing
for home use. The Food and Drug Administration
also places a premium on at-home molecular
diagnostic testing in 2021. The COVID-19
detection self-test kit was introduced in March
2021 by BATM Advanced Communications Ltd. The
risk of substitution is minimal because these
tests provide early disease detection. Patients
may seek out non-internal options due to the high
cost of these testing. Furthermore, due to the
high rate of internal substitution, competition
is strong in the case of identification of novel
viruses such as SARS-CoV-2. Existing players' IVD
product penetration is poor in places like APAC.
Local musicians dominate the scene and offer more
affordable instrument prices. One of the primary
factors pushing this industry forward is the
development of portable, accurate, and
cost-effective technologies.The report covers the
period from 2017 to 2030, with 2022 serving as
the base year, and provides

7
By Region
The North American market was valued at USD 35.92
billion in 2021 and is expected to continue to
dominate the global market during the forecast
period. Some of the prominent factors
contributing to the region's highest share
include the presence of major corporations in the
region, such as Abbott, Thermo Fisher Scientific
Inc., Becton, Dickinson and Company, and Danaher
Corporation, as well as appropriate and favorable
government regulations. - Established diagnostic
infrastructure and adoption of technologically
advanced diagnostic techniques. Europe is
expected to be the second dominant region in
terms of in vitro diagnostics market share. The
market in Europe holds a significant share due to
rising healthcare spending, well-established
infrastructure, large patient pool suffering from
infectious diseases and cancer. The Asia-Pacific
market is expected to grow at the highest CAGR,
especially in developing countries such as India,
South Korea, Australia, and China. Improvements
in authorization and reimbursement policies and
increasing per capita healthcare spending in the
region are expected to drive the market growth in
Asia Pacific during 2022-2029. For example, in
April 2021, Seegene Inc. announced that it had
received export permission from the Korean
Ministry of Food and Drug Safety to export its
COVID-19 mutation test to countries around the
world. This license will strengthen the company's
sales and market position worldwide.
8
The Global IVD Market has been segmented into

• By Type
• Instruments
• Reagents Consumables

• By Technique
• Immunodiagnostics
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Others

• By Setting
• Laboratories
• Point-of-care

• By Application
• Infectious Diseases
• Cardiology
• Oncology
• Gastroenterology
• Others

• By End-user
• Clinical Laboratories
• Hospitals
• Physicians Offices
• Others

9
The Global IVD Market has been segmented into

• By Region
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe

• By Region
• North America
• US
• Canada
• Mexico
• Rest of North America
• The Middle East Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

• By Region
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific

10
Market Dynamics
Multiple disorders, including those with a
hereditary component, a cardiovascular component,
and a neurological component, are on the rise.
The World Health Organization (WHO) reports that
heart disease and other forms of cardiovascular
disease kill 17.9 million people per year.
Overall market growth can be attributed to rising
routine diagnosis and public awareness of the
need of early diagnosis. The rapid expansion of
the industry is being bolstered by the launch of
novel, cutting-edge IVD products.In addition,
various ailments, including hypertension,
diabetes, cardiovascular, liver, and kidney
disorders, are projected to increase dramatically
along with the aging population.An article in
Knoema from 2021 claims that the percentage of
people 65 and older in the world was 9.5. As a
result, the global market is expected to grow
much faster than expected.Over the past decade,
in vitro diagnostic devices have undergone
tremendous development and advancement thanks to
the introduction of new products and the adoption
of additional design adjustments. The market's
expansion has been stymied, however, by the high
purchase and maintenance prices of in vitro
diagnostic equipment. In addition, only qualified
personnel should use in vitro diagnostic
equipment. As a result, the device's upkeep costs
rise, slowing the market's expansion as a
whole.The price tag for an RT-PCR machine
averages around 15,000. As a result of the
aforementioned price barriers, in vitro
diagnostic products have been slower to gain
traction in some locations.
11
Market Players

• F. Hoffmann-La Roche Ltd (Switzerland),
• Abbott Laboratories (U.S.),
• Thermo Fisher Scientific Inc. (U.S.),
• Sysmex Corporation (Japan),
• Siemens Healthineers AG (Germany),
• BD (Becton,
• Dickinson,
• Company) (U.S.),
• Seegene Inc. (Republic of Korea),
• DiaSorin S.p.A. (Italy),
• Quest Diagnostics Incorporated (U.S.),
• Bio-Rad Laboratories, Inc. (U.S.)

12
Customer Experiences
13

• By associating with Contrive Datum Insights (CDI)
  , customer can enjoy following benefits
• One-Stop-Destination for all research needs
  (Syndicate and Custom Reports)
• Reduced Budget and Faster Turnaround Time
• Focused Research Team - Contrive Datum Insights
  (CDI) can arrange a dedicated team of 2-3
  resources with 1 Research Manager , who will look
  after any ad-hoc needs of the client
• Dedicated Account Manager
• 24/7 availability for any custom needs of the
  client
• Flexible Partnering Model to accommodate clients
  research needs
• Access to Data-Cuts related to required Market
  for global region
• ? Industry Update on Weekly/Bi-Weekly/Monthly
  basis
• ? Market Trend Analysis on Monthly/Quarterly basis

Benefits of Association
14
Thank You!
To know more about us, please visit our website
www.contrivedatuminsights.com For sales queries
or new topics email us on anna_at_contrivedatuminsig
hts.com